Your genes could guide your pain meds: new study tests personalized prescribing
NCT ID NCT06511401
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether giving doctors genetic information about their patients can help them choose safer and more effective pain medications. Researchers will enroll 800 cancer patients who are expected to need opioid painkillers. Half will have their genes tested to guide prescribing, while the other half will receive standard care. The goal is to see if the genetic approach leads to better pain control and fewer medication changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pharmacogenomic (PGx) testing
- What this could lead to
- If successful, this could show that using a person's genetic information helps doctors pick the right pain medicine and dose, leading to better pain control with fewer side effects.
- What could go wrong
- This is an early-stage study (Phase N/A) with 800 participants. It's testing a process, not a new drug, so the direct benefit to patients may be small or unclear. Results may not apply to all cancer patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT PATIENTS WHO ARE RECEIVING ONCOLOGIC CARE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Chicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?